Your browser doesn't support javascript.
loading
Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears.
Eckardt, Jan-Niklas; Middeke, Jan Moritz; Riechert, Sebastian; Schmittmann, Tim; Sulaiman, Anas Shekh; Kramer, Michael; Sockel, Katja; Kroschinsky, Frank; Schuler, Ulrich; Schetelig, Johannes; Röllig, Christoph; Thiede, Christian; Wendt, Karsten; Bornhäuser, Martin.
Afiliación
  • Eckardt JN; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany. jan-niklas.eckardt@uniklinikum-dresden.de.
  • Middeke JM; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Riechert S; Institute of Circuits and Systems, Technical University Dresden, Dresden, Germany.
  • Schmittmann T; Institute of Circuits and Systems, Technical University Dresden, Dresden, Germany.
  • Sulaiman AS; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Kramer M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Sockel K; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Kroschinsky F; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Schuler U; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Wendt K; Institute of Circuits and Systems, Technical University Dresden, Dresden, Germany.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
Leukemia ; 36(1): 111-118, 2022 01.
Article en En | MEDLINE | ID: mdl-34497326
ABSTRACT
The evaluation of bone marrow morphology by experienced hematopathologists is essential in the diagnosis of acute myeloid leukemia (AML); however, it suffers from a lack of standardization and inter-observer variability. Deep learning (DL) can process medical image data and provides data-driven class predictions. Here, we apply a multi-step DL approach to automatically segment cells from bone marrow images, distinguish between AML samples and healthy controls with an area under the receiver operating characteristic (AUROC) of 0.9699, and predict the mutation status of Nucleophosmin 1 (NPM1)-one of the most common mutations in AML-with an AUROC of 0.92 using only image data from bone marrow smears. Utilizing occlusion sensitivity maps, we observed so far unreported morphologic cell features such as a pattern of condensed chromatin and perinuclear lightening zones in myeloblasts of NPM1-mutated AML and prominent nucleoli in wild-type NPM1 AML enabling the DL model to provide accurate class predictions.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia Mieloide Aguda / Biomarcadores de Tumor / Aprendizaje Profundo / Nucleofosmina / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia Mieloide Aguda / Biomarcadores de Tumor / Aprendizaje Profundo / Nucleofosmina / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania